Jean Coutu sales up but profit weighed by generic prices - BNN Bloomberg

The Quebec-based pharmacy company had $47.8 million or 26 cents per share of net income in its fourth quarter, ended March 4 — down seven per cent from the comparable period last year.

Grocers brace for generic drug deal; Loblaw stock downgraded by Desjardins - BNN Bloomberg

How Not to Negotiate a $6.1 Billion Deal - Bloomberg

Novo Nordisk Forecasts Record Profit Fueled by Obesity Drug - Bloomberg

Obesity Drug WeGovy to Drive Up Profits at Novo Nordisk - Bloomberg

SCRAM-CAM-Guide-Image

Jean Coutu Q1 revenue up, profit down on Pro Doc brand - BNN Bloomberg

Inflation Story Spun by CEOs Is Debunked by Fat Profit Margins - Bloomberg

Business and Finance News

Inflation Story Spun by CEOs Is Debunked by Fat Profit Margins - Bloomberg

Solved Assume that projected revenue for 2018 is 1,231,414.

JOURNAL OF INTERNATIONAL BUSINESS & LAW - Hofstra Law

Where Bits and Bytes Meet Brick-and-Mortar Retail